Promoting weight loss in the obese patient

Patient Care

Volumn 34, Issue 7, 2000, Pages 204-218

  Huber, Gary L ^a   Raines, Jason W ^b,c  

^a EAST TEXAS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Texas Nutrition Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4344640045     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. The Evidence Report National Institutes of Health. Bethesda, MD: National Heart, Lung, and Blood Institute. National Institute of Diabetes and Digestive and Kidney Diseases. NIH publication no. 98-4083, 1998.
2. Wolf AM, Colditz GA. Social and economic effects of body weight in the United States. Am J Clin Nutr. 1996;63(3 Suppl):466S.
3. Seidell JC. The impact of obesity on health status: some implications for health care costs. Int J Obes Relat Metab Disord. 1995;19(Suppl 6):S13.
4. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA. 1993;270(18):2207.
5. Najjar MF, Kuczmarski RJ. Anthropometric data and prevalence of overweight for Hispanics: 1982-84. Vital Health Stat 11. 1989;(239):1.
6. Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993;153(9):1093.
7. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968.
8. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333(11):677.
9. Thomas PR (ed). Weighing the Options: Criteria for Evaluating Weight-Management Programs. Washington, DC, National Academy Press, 1995.
10. Methods for voluntary weight loss and control. Technology Assessment Conference NIH Panel. Consensus Development Conference, 30 March to 1 April 1992. Ann Intern Med. 1993;119(7 Pt 2):764.
11. Very low-calorie diets. National Task Force on the Prevention and Treatment of Obesity. National Institutes of Health. JAMA. 1993;270(8):967.
12. Van Gaal LF: Dietary treatment of obesity, in Bray GA, Bouchard C, James WP (eds). Handbook of Obesity. New York, M. Dekker, 1998, pp 875-890.
13. Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity. JAMA. 1996;276 (23):1907.
14. Bray GA. Pharmacological treatment of obesity, in Bray GA, Bouchard C, James WP (eds): Handbook of Obesity. New York, M. Dekker, 1998, pp 953-975.
15. Atkinson RL: Use of drugs in the treatment of obesity. Annu Rev Nutr. 1997;17:383.
16. Weintraub M. Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study [published erratum appears in Clin Pharmacol Ther. 1992;52(3):323]. Clin Pharmacol Ther. 1992;51(5):581.
17. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine [published erratum appears in N Engl J Med. 1997;337(24):1783]. N Engl J Med 1997;337(9):581.
18. Bray GA, Ryan DH, Gordon D, et al. A double-blind randomized placebo-controlled trial of sibutramine. Obes Res. 1996;4(3):263.
19. Campfield LA. Proceedings Interaction Symposium on Obesity: Advances in Understanding and Treatment International Business Communications, 1995.